⌘K

Login Start Free

Home/Filings/4/0001562180-18-000718

4//SEC Filing

Chen Henry 4

Accession 0001562180-18-000718

CIK 0001395937other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:00 PM ET

Size

5.4 KB

Accession

0001562180-18-000718

Insider Transaction Report

Form 4

Period: 2018-02-08

Syndax Pharmaceuticals IncSNDX

Director

Transactions

Award
Stock Option (Right to Buy)
2018-02-08+10,000→ 10,000 total
Exercise: $9.63Exp: 2028-02-08→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]1/36th of the shares subject to the option shall vest monthly over a three-year period.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1

filerCIK 0001667481

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 4:00 PM ET
Size: 5.4 KB

View on SEC.gov